Clinical trial
Testosterone Gel Applied to Women With Pituitary Gland Problems
NCT00144391 · Charles Drew University of Medicine and Science, Other · Completed
Key facts
| NCT number | NCT00144391 |
|---|---|
| Title | Testosterone Gel Applied to Women With Pituitary Gland Problems |
| Official title | Physiologic Testosterone Replacement in Women With Hypopituitarism |
| Lead sponsor | Charles Drew University of Medicine and Science, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Panhypopituitarism |
| Intervention type | Drug |
| Interventions | Transdermal Testosterone gel |
| Enrollment | 20 |
| Start date | Jul 1, 2003 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 5, 2005 |
| Last update posted | Jun 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: